Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Avanir Pharmaceuticals, Inc.
- Webcast to Begin at 12:30 p.m. Eastern time -
ALISO VIEJO, Calif., Oct. 23, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will host a live webcast in conjunction with its Investor Relations Day on Tuesday, October 29, 2013 at 12:30 p.m. ET in New York City.
To view and listen to the webcast please visit our website at http://ir.avanir.com. Visitors will also be able to view and listen to an archive copy of the webcast found in the Investor Relations section of www.avanir.com. The archive will be available for 30 days following the event.
For more information on the Investor Relations Day please refer to contact information within this press release.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.
AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.
©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.
Avanir Investor & Media Contact
Ian Clements, PhD
+1 (949) 389-6700
Burns McClellan Contact
+1 (212) 213-0006
©2012 PR Newswire. All Rights Reserved.